But/CC/O in/IN/O certain/JJ/O conditions/NNS/O such/JJ/O as/IN/O autoimmune/JJ/O diseases/NNS/O and/CC/O allergies/NNS/O and/CC/O transplant/NN/O rejection/NN/O ,/,/O doctors/NNS/O would/MD/O like/VB/O to/TO/O damp/VB/O the/DT/O immune/JJ/O response/NN/O so/IN/O such/JJ/O cells/NNS/O do/VBP/O n't/RB/O touch/VB/O off/RP/O harmful/JJ/O inflammatory/JJ/O reactions/NNS/O or/CC/O cell/NN/O destruction/NN/O ././O
A/DT/O soluble/JJ/O form/NN/O of/IN/O the/DT/O receptor/NN/O might/MD/O turn/VB/O off/RP/O a/DT/O specific/JJ/O part/NN/O of/IN/O the/DT/O immune/JJ/O response/NN/O without/IN/O general/JJ/O immune/JJ/O suppression/NN/O ,/,/O the/DT/O company/NN/O said/VBD/O ././O
Immunex/NNP/B-ORG will/MD/O contract/VB/O with/IN/O the/DT/O spinoff/NN/O to/TO/O provide/VB/O the/DT/O research/NN/O ,/,/O development/NN/O and/CC/O initial/JJ/O testing/NN/O of/IN/O the/DT/O new/JJ/O agents/NNS/O ././O
Immunex/NNP/B-ORG will/MD/O have/VB/O the/DT/O option/NN/O to/TO/O buy/VB/O back/RP/O Receptech/NNP/B-ORG shares/NNS/O after/IN/O five/CD/O years/NNS/O ././O
